Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 3, 2011, Pages 336-345

  Chang, Laura M ^a,b   Maheshwari, Prateesh ^a,b   Werth, Sheila ^a   Schaffer, Lana ^d,e   Head, Steven R ^d,e   Kovarik, Carrie ^a,c   Werth, Victoria P ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d DNA Array Core Facility   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Chondroitin sulfate; Cutaneous lupus erythematosus; Dermatomyositis; Glycosaminoglycans; Hyaluronan

Indexed keywords

CHONDROITIN SULFATE; HYALURONIC ACID;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DERMATOMYOSITIS; DERMIS; DISCOID LUPUS ERYTHEMATOSUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN LUPUS ERYTHEMATOSUS; TUMID LUPUS ERYTHEMATOSUS;

ANTIGENS, CD3; CASE-CONTROL STUDIES; CHONDROITIN SULFATES; DERMATOMYOSITIS; DERMIS; HUMANS; HYALURONIC ACID; LUPUS ERYTHEMATOSUS, CUTANEOUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

DISCOIDAE;

EID: 80051709680     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155410398000     Document Type: Article

References (44)

1. Ackerman AB, Chongchitnant N, Sanchez J, Guo Y, Bennin B, Reichel M. 1997. Histologic diagnosis of inflammatory skin diseases: an algorithmic method based on pattern analysis. Baltimore: Lippincott Williams & Wilkins.
2. Agren UM, Tammi RH, Tammi MI. 1997. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med. 23:996-1001.
3. Averbeck M, Gebhardt CA, Voigt S, Beilharz S, Anderegg U, Termeer CC, Sleeman JP, Simon JC. 2007. Differential regulation of hyaluronan metabolism in the epidermal and dermal compartments of human skin by UVB irradiation. J Invest Dermatol. 127:687-697.
4. Avnur Z, Geiger B. 1984. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell. 38:811-822.
5. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics. 19:185-193.
6. Bray BA, Sampson PM, Osman M, Giandomenico A, Turino GM. 1991. Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters. Am Rev Respir Dis. 143:284-288.
7. Comelli EM, Head SR, Gilmartin T, Whisenant T, Haslam SM, North SJ, Wong NK, Kudo T, Narimatsu H, Esko JD, et al. 2006. A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology. 16:117-131.
8. Crowson AN, Magro C. 2001. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol. 28:1-23.
9. Daugaard S, Strange L, Schit T. 1991. Immunohistochemical staining for chondroitin sulfate and keratan sulphate: an evaluation of two monoclonal antibodies. Histochemistry. 95:585-589.
10. DeGrendele HC, Estess P, Picker LJ, Siegelman MH. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte/endothelial cell primary adhesion pathway. J Exp Med. 183:1119-1130.
11. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA. 2003. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 163:121-133.
12. Esford LE, Maiti A, Bader SA, Tufaro F, Johnson P. 1998. Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate. J Cell Sci. 111:1021-1029.
13. Fioravanti A, Collodel G. 2006. In vitro effects of chondroitin sulfate. Adv Pharmacol. 53:449-465.
14. Gebhardt C, Averbeck M, Diedenhofen N, Willenberg A, Anderegg U, Sleeman JP, Simon JC. 2010. Dermal hyaluronan is rapidly reduced by topical treatment with glucocorticoids. J Invest Dermatol. 130:141-149.
15. Gee K, Kryworuchko M, Kumar A. 2004. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases. Arch Immunol Ther Exp. 52:13-26.
16. Gilliam JN, Sontheimer RD. 1981. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 4:471-475.
17. Hascall VC, Heinegå D. 1974. Aggregation of cartilage proteoglycans: II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J Biol Chem. 249:4242-4249.
18. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdick MD, Strieter RM, Trinchieri G, PuréE. 1997. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol. 159:2492-2500.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
20. Ito Y, Hikino M, Yajima Y, Mikami T, Sirko S, von Holst A, Faissner A, Fukui S, Sugahara K. 2005. Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology. 15:593-603.
21. Izumikawa T, Koike T, Shiozawa S, Sugahara K, Tamura J, Kitagawa H. 2008. Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization. J Biol Chem. 283:11396-11406.
22. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 11:1173-1179.
23. Jiang D, Liang J, Noble PW. 2007. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 23:435-461.
24. Kuhn A, Sticherling M, Bonsmann G. 2007. Clinical manifestations of cutaneous lupus erythematosus. J German Soc Dermatol. 5:1124-1137.
25. Levitt D, Ho P. 1983. Induction of chondroitin sulfate proteoglycan synthesis and secretion in lymphocytes and monocytes. J Cell Biol. 97:351-358.
26. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, et al. 1996. Expression monitoring by hybridization to high density oligonucleotide arrays. Nat Biotechnol. 14:1675-1680.
27. McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC, Kubes P. 2008. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med. 205:915-927.
28. Meller S, Homey B, Ruzicka T. 2005. Socioeconomic factors in lupus erythematosus. Autoimmun Rev. 4:242-246.
29. Moghadam-Kia S, Chilek K, Gaines E, Costner M, Rose M, Okawa J, Werth VP. 2009. Cross-sectional analysis of a collaborative Web-based database for lupus erythematosusassociated skin lesions: prospective enrollment of 114 patients. Arch Dermatol. 145:255-260.
30. Rachmilewitz J, Tykocinski ML. 1998. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood. 92:223-229.
31. Ruffell B, Johnson P. 2005. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding. Biochem Biophys Res Commun. 334:306-312.
32. Sontheimer RD, Provost TT. 2004. Cutaneous manifestations of rheumatic diseases. Philadelphia: Lippincott Williams & Wilkins.
33. Tammi R, Agren UM, Tuhkanen AL, Tammi M. 1994. Hyaluronan metabolism in skin. Prog Histochem Cytochem. 29:1-81.
34. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20:9-22.
35. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. 2007. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem. 282:18265-18275.
36. Tebbe B, Orfanos CE. 1997. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus. 6: 96-104.
37. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Tolllike receptor 4. J Exp Med. 195:99-111.
38. Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR. 2006. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant. 6:2622-2635.
39. Wang C, Tammi M, Tammi R. 1992. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry. 98:105-112.
40. Weigel PH, Hascall VC, Tammi M. 1997. Hyaluronan synthases. J Biol Chem. 272:13997-14000.
41. Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tüing T. 2006. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol. 31:576-582.
42. Xiao Z, Visentin GP, Dayananda KM, Neelamegham S. 2008. Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion. Blood. 112:1091-1100.
43. Xu CX, Jin H, Chung YS, Shin JY, Woo MA, Lee KH, Palmos GN, Choi BD, Cho MH. 2008. Chondroitin sulfate extracted from the Styela clava tunic suppresses TNF-alpha-induced expression of inflammatory factors, VCAM-1 and iNOS by blocking Akt/NF-jB signal in JB6 cells. Cancer Lett. 264:93-100.
44. Zhang W, Watson CE, Liu C, Williams KJ, Werth VP. 2000. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy. Biochem J. 349:91-97.